Could Toxomplasma gondii infection be dangerous? - Systematic review
DOI:
https://doi.org/10.12775/JEHS.2023.34.01.009Keywords
toxoplasmosis, toxoplasma gondii, congenital toxoplasmosis, pregnacyAbstract
Introduction: Toxoplasma gondii is an intracellular protozoan commonly found in humans in the form of three main forms: tachyzoite, tissue cyst and oocyst. The definitive host is the Felidae family, and one of the intermediate hosts is humans. The most common routes of infection are ingestion of raw or undercooked meat, water and food contaminated with oocysts. Among the forms of infection, we distinguish between the acquired form and the much more dangerous congenital form.
Aim of the study: The objective of the study was to rewiev the literature describing the dangerous impact of Toxoplasma gondii infection on human.
Methods and materials: : We reviewed the literature available in the PubMed database, using the key words: "toxoplasma gondii"; "congenital toxoplasmosis"; "pregnacy".
Results: T. gondii infection is particularly dangerous in pregnant women, due to the high risk of vertical transmission of the infection to the developing fetus. The clinical presentation of congenital toxoplasmosis depends on the gestational age at which the infection occurred. Pathognomonic signs of congenital toxoplasmosis include Sabin-Pinkerton Triad, which includes inflammation of the retina and choroid of the eye, dilatation of the brain's ventricular system and intracranial calcifications. Available pharmacotherapy works on tachyzoites present in the initial phase of acquired infection, congenital infection and reactivated infection in immunodeficient patients, available drugs do not work on tissue cysts.
Conclusion: The consequences of Toxoplasma gondii infection are particularly dangerous for the fetus, so pregnant women should pay special attention to hand hygiene and thorough washing of the food they eat. For this reason, it is extremely important to educate pregnant women about health issues and draw attention to the possible consequences of T.gondii infection.
References
Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004 Jun 12;363(9425):1965-76. doi: 10.1016/S0140-6736(04)16412-X. PMID: 15194258.
Attias M, Teixeira DE, Benchimol M, et al. The life-cycle of Toxoplasma gondii reviewed using animations. Parasit Vectors. 2020 Nov 23;13(1):588. doi: 10.1186/s13071-020-04445-z. PMID: 33228743; PMCID: PMC7686686.
Robert-Gangneux F, Dardé ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev. 2012 Apr;25(2):264-96. doi: 10.1128/CMR.05013-11. Erratum in: Clin Microbiol Rev. 2012 Jul;25(3):583. PMID: 22491772; PMCID: PMC3346298.
Liu Q, Wang ZD, Huang SY, Zhu XQ. Diagnosis of toxoplasmosis and typing of Toxoplasma gondii. Parasit Vectors. 2015 May 28;8:292. doi: 10.1186/s13071-015-0902-6. PMID: 26017718; PMCID: PMC4451882.
Halonen SK, Weiss LM. Toxoplasmosis. Handb Clin Neurol. 2013;114:125-45. doi: 10.1016/B978-0-444-53490-3.00008-X. PMID: 23829904; PMCID: PMC4157368.
Paquet C, Yudin MH; Society of Obstetricians and Gynaecologists of Canada. Toxoplasmosis in pregnancy: prevention, screening, and treatment. J Obstet Gynaecol Can. 2013 Jan;35(1):78-81. English, French. doi: 10.1016/s1701-2163(15)31053-7. PMID: 23343802.
Ozgonul C, Besirli CG. Recent Developments in the Diagnosis and Treatment of Ocular Toxoplasmosis. Ophthalmic Res. 2017;57(1):1-12. doi: 10.1159/000449169. Epub 2016 Oct 11. PMID: 27723657.
Dini FM, Morselli S, Marangoni A, et al. Spread of Toxoplasma gondii among animals and humans in Northern Italy: A retrospective analysis in a One-Health framework. Food Waterborne Parasitol. 2023 Jun 8;32:e00197. doi: 10.1016/j.fawpar.2023.e00197. PMID: 37333686; PMCID: PMC10273278.
Lüder CGK, Rahman T. Impact of the host on Toxoplasma stage differentiation. Microb Cell. 2017 Jun 22;4(7):203-211. doi: 10.15698/mic2017.07.579. PMID: 28706936; PMCID: PMC5507683.
Stelzer S, Basso W, Benavides Silván J, et al. Toxoplasma gondii infection and toxoplasmosis in farm animals: Risk factors and economic impact. Food Waterborne Parasitol. 2019 Apr 3;15:e00037. doi: 10.1016/j.fawpar.2019.e00037. PMID: 32095611; PMCID: PMC7033994.
Hampton MM. Congenital Toxoplasmosis: A Review. Neonatal Netw. 2015;34(5):274-8. doi: 10.1891/0730-0832.34.5.274. PMID: 26802827.
Dard C, Marty P, Brenier-Pinchart MP, et al. Management of toxoplasmosis in transplant recipients: an update. Expert Rev Anti Infect Ther. 2018 Jun;16(6):447-460. doi: 10.1080/14787210.2018.1483721. Epub 2018 Jul 2. PMID: 29855213.
Karimi G, Mardani A, Zadsar M. Prevalence of Toxoplasma gondii among Iranian Blood Donors: A Narrative Review Article. Iran J Parasitol. 2016 Jan-Mar;11(1):10-8. PMID: 27095963; PMCID: PMC4835458.
Dubey JP. The history of Toxoplasma gondii--the first 100 years. J Eukaryot Microbiol. 2008 Nov-Dec;55(6):467-75. doi: 10.1111/j.1550-7408.2008.00345.x. PMID: 19120791.
Fabiani S, Caroselli C, Menchini M, et al. Ocular toxoplasmosis, an overview focusing on clinical aspects. Acta Trop. 2022 Jan;225:106180. doi: 10.1016/j.actatropica.2021.106180. Epub 2021 Oct 23. PMID: 34699742.
Kochanowsky JA, Koshy AA. Toxoplasma gondii. Curr Biol. 2018 Jul 23;28(14):R770-R771. doi: 10.1016/j.cub.2018.05.035. PMID: 30040931.
Azovtseva OV, Viktorova EA, Bakulina EG et al. Cerebral toxoplasmosis in HIV-infected patients over 2015-2018 (a case study of Russia). Epidemiol Infect. 2020 May 4;148:e142. doi: 10.1017/S0950268820000928. PMID: 32364106; PMCID: PMC7374806.
Pleyer U, Gross U, Schlüter D, et al. Toxoplasmosis in Germany. Dtsch Arztebl Int. 2019 Jun 21;116(25):435-444. doi: 10.3238/arztebl.2019.0435. PMID: 31423982; PMCID: PMC6706837.
Sanchez SG, Besteiro S. The pathogenicity and virulence of Toxoplasma gondii. Virulence. 2021 Dec;12(1):3095-3114. doi: 10.1080/21505594.2021.2012346. PMID: 34895084; PMCID: PMC8667916.
Vidal JE. HIV-Related Cerebral Toxoplasmosis Revisited: Current Concepts and Controversies of an Old Disease. J Int Assoc Provid AIDS Care. 2019 Jan-Dec;18:2325958219867315. doi: 10.1177/2325958219867315. PMID: 31429353; PMCID: PMC6900575.
Elsheikha HM, Marra CM, Zhu XQ. Epidemiology, Pathophysiology, Diagnosis, and Management of Cerebral Toxoplasmosis. Clin Microbiol Rev. 2020 Nov 25;34(1):e00115-19. doi: 10.1128/CMR.00115-19. PMID: 33239310; PMCID: PMC7690944.
Czech T, Shah P, Lee G, et al. Cerebral toxoplasmosis in a patient with combined variable immunodeficiency. Surg Neurol Int. 2022 Aug 12;13:354. doi: 10.25259/SNI_532_2022. PMID: 36128152; PMCID: PMC9479566.
Tong WH, Pavey C, O'Handley R, Vyas A. Behavioral biology of Toxoplasma gondii infection. Parasit Vectors. 2021 Jan 25;14(1):77. doi: 10.1186/s13071-020-04528-x. PMID: 33494777; PMCID: PMC7831251.
Abdelbaset AE, Abushahba MFN, Igarashi M. Toxoplasma gondii in humans and animals in Japan: An epidemiological overview. Parasitol Int. 2022 Apr;87:102533. doi: 10.1016/j.parint.2021.102533. Epub 2021 Dec 27. PMID: 34968753.
Kalogeropoulos D, Sakkas H, Mohammed B, et al. Ocular toxoplasmosis: a review of the current diagnostic and therapeutic approaches. Int Ophthalmol. 2022 Jan;42(1):295-321. doi: 10.1007/s10792-021-01994-9. Epub 2021 Aug 9. PMID: 34370174; PMCID: PMC8351587.
AB, Budoff G, McCannel CA, et al. Ocular Toxoplasmosis: No Stranger to the Masquerade Ball. J Vitreoretin Dis. 2021 Dec 7;6(5):391-398. doi: 10.1177/24741264211056769. PMID: 37006900; PMCID: PMC9954925.
Kalogeropoulos D, Kalogeropoulos C, Sakkas H, et al. Pathophysiological Aspects of Ocular Toxoplasmosis: Host-parasite Interactions. Ocul Immunol Inflamm. 2022 Apr 3;30(3):560-569. doi: 10.1080/09273948.2021.1922706. Epub 2021 Jul 9. PMID: 34242103.
Greigert V, Bittich-Fahmi F, Pfaff AW. Pathophysiology of ocular toxoplasmosis: Facts and open questions. PLoS Negl Trop Dis. 2020 Dec 31;14(12):e0008905. doi: 10.1371/journal.pntd.0008905. PMID: 33382688; PMCID: PMC7774838.
Kieffer F, Wallon M. Congenital toxoplasmosis. Handb Clin Neurol. 2013;112:1099-101. doi: 10.1016/B978-0-444-52910-7.00028-3. PMID: 23622316
Mandelbrot L, Kieffer F, Wallon M et al. Toxoplasmosis in pregnancy: Practical Management. Gynecol Obstet Fertil Senol. 2021 Oct;49(10):782-791. doi: 10.1016/j.gofs.2021.03.003. Epub 2021 Mar 5.
Ahmed M, Sood A, Gupta J. Toxoplasmosis in pregnancy. Eur J Obstet Gynecol Reprod Biol. 2020 Dec;255:44-50. doi: 10.1016/j.ejogrb.2020.10.003. Epub 2020 Oct 8. PMID: 33075679
Markowska A, Połczyńska-Kaniak E. Toksoplazmoza a ciąża. Ginekologia po dyplomie. Maj 2010.
Saadatnia G, Golkar M. A review on human toxoplasmosis. Scand J Infect Dis. 2012 Nov;44(11):805-14. doi: 10.3109/00365548.2012.693197. Epub 2012 Jul 25. PMID: 22831461.
Montoya JG. Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. J Infect Dis. 2002 Feb 15;185 Suppl 1:S73-82. doi: 10.1086/338827. PMID: 11865443.
Liesenfeld O, Montoya JG, Tathineni NJ, et al. Confirmatory serologic testing for acute toxoplasmosis and rate of induced abortions among women reported to have positive Toxoplasma immunoglobulin M antibody titers. Am J Obstet Gynecol. 2001 Jan;184(2):140-5. doi: 10.1067/mob.2001.108341. PMID: 11174493.
Beghetto E, Buffolano W, Spadoni A, et al. Use of an immunoglobulin G avidity assay based on recombinant antigens for diagnosis of primary Toxoplasma gondii infection during pregnancy. J Clin Microbiol. 2003 Dec;41(12):5414-8. doi: 10.1128/JCM.41.12.5414-5418.2003. PMID: 14662919; PMCID: PMC308957.
Ashburn D, Joss AW, Pennington TH, Ho-Yen DO. Do IgA, IgE, and IgG avidity tests have any value in the diagnosis of toxoplasma infection in pregnancy? J Clin Pathol. 1998 Apr;51(4):312-5. doi: 10.1136/jcp.51.4.312. PMID: 9659246; PMCID: PMC500678.
Francis JM, Joynson DH. Duration of specific immunoglobulin A antibody following acute toxoplasmosis as determined by enzyme immunoassay and immunosorbent agglutination assay. Eur J Clin Microbiol Infect Dis. 1993 Jul;12(7):556-9. doi: 10.1007/BF01970965. PMID: 8404920.
Montoya JG, Remington JS. Management of Toxoplasma gondii infection during pregnancy. Clin Infect Dis. 2008 Aug 15;47(4):554-66. doi: 10.1086/590149. PMID: 18624630.
Bessières MH, Berrebi A, Rolland M, et al. Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal tests. Eur J Obstet Gynecol Reprod Biol. 2001 Jan;94(1):37-45. doi: 10.1016/s0301-2115(00)00300-6. PMID: 11134824
Madireddy S, Rivas Chacon ED, Mangat R. Toxoplasmosis. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan.2022 Sep 26.PMID: 33085433
Derouin F. Anti-toxoplasmosis drugs. Curr Opin Investig Drugs.2001 Oct;2(10):1368-74. PMID: 11890349
Chaudhry SA, Gad N, Koren G. Toxoplasmosis and pregnancy. Can Fam Physician. 2014 Apr; 60(4): 334-336. PMCID: PMC4046541.PMID: 24733322
Bollani L, Auriti C, Achille C, et al. Congenital Toxoplasmosis: The State of the Art. Front Pediatr. 2022; 10: 894573. PMCID: PMC9301253. PMID: 35874584
Müller J, Hemphill A. Toxoplasma gondii infection: novel emerging therapeutic targets. Expert Opin Ther Targets. 2023 Apr-May;27(4-5):293-304. doi: 10.1080/14728222.2023.2217353. Epub 2023 May 24. PMID: 37212443.
Smith NC, Goulart C, Hayward JA, et al. Control of human toxoplasmosis. Int J Parasitol. 2021 Feb;51(2-3):95-121. doi: 10.1016/j.ijpara.2020.11.001. Epub 2020 Dec 19. PMID: 33347832.
Teimouri A, Mohtasebi S, Kazemirad E, et al. Role of Toxoplasma gondii IgG Avidity Testing in Discriminating between Acute and Chronic Toxoplasmosis in Pregnancy. J Clin Microbiol. 2020 Aug 24;58(9):e00505-20. doi: 10.1128/JCM.00505-20. PMID: 32321784; PMCID: PMC7448626.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Gabriela Frącz, Klaudia Kuliga, Marcin Kuliga, Kinga Musz, Agnieszka Socha, Kinga Śnieżek
![Creative Commons License](http://i.creativecommons.org/l/by-nc-sa/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 345
Number of citations: 0